A Meeting Of The Migraine Minds - Top U.S. Migraine Specialist To Present New Treatments At International Headache Congress In Brazil In September

South Florida Sun Times

Sep 3, 2025

Climate Change, Hormonal Shifts, And Increased Screen Times Know No Geographical Boundaries And Unfortunately, Are A Few Of The Most Prevalent Triggers That Have Been Causing A Rise In Migraine Incidences Around The World. In Fact, According To The National Institute Of Health, In 2025, 3.1 billion People Worldwide Are Estimated To Be Living With Migraine, And It Is The #1 Cause Of Disability For Women Ages 18-50. To Reverse This Trend, Top Medical Experts In The Headache Field Will Gather Next Month To Share Knowledge And Learn About The Latest Advances In Migraine Diagnosis And Treatment At The International Headache Congress (IHC) In Sao Paolo, Brazil From Wednesday, September 10th - Sunday, September 14th, 2025. One Of Those Renowned Colleagues Is Dr. Fred Cohen, Founder Of Headache Intervention, PLLC, A Migraine Specialty Practice In New York And Florida, And Assistant Professor Of Medicine And Neurology At The Icahn School Of Medicine At Mount Sinai In New York, Who Will Be Presenting A Lecture On Acute Migraine Treatments And Will Also Chair And Moderate Sessions On The Latest Clinical Developments In Headache Medicine.

“As a lifelong sufferer of chronic headaches, I understand the pain and frustration of what migraine patients experience on a daily basis,” said Dr. Cohen. “Finding relief by seeking a highly skilled headache specialist is what transformed my life back then and what inspires me to do this type of work today. Knowledge is power and this international conference will offer hope to billions of people as many new interventions will be discussed that can be used to alleviate their headache burden as well.”

Specifically, Dr. Cohen’s seminar will focus on the mechanism of action of nonsteroidal anti-inflammatory drugs (NSAIDs) in treating migraines by discussing common over-the-counter options for headaches, such as ibuprofen, naproxen, and aspirin, as well as prescription NSAIDs including diclofenac and ketorolac. His presentation will also highlight Symbravo, a newly approved combination therapy that pairs the triptan rizatriptan with the NSAID meloxicam.

Besides Dr. Cohen’s presentation, other innovative topics to be discussed at the upcoming IHC include:

• Exploring the role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) during the migraine attack cycle

• AI in the fight against migraine

• Gender differences in response to acute and preventive treatment of migraine

• Cluster headache and insights for the role of anti-CGRPs in acute and prophylactic treatment

• Migraine in pregnancy and lactation

• Migraine effect on cognitive functions

“Migraine research is advancing rapidly, with many fascinating new therapies emerging,” adds Dr. Cohen. “Just as everyone’s headache triggers are unique, so too are their treatment choices. No one should have to suffer in debilitating pain anymore.”

For 22 years, the IHC has attracted top neurologists, scientists and health professionals in related fields from around the world. This year’s conference entitled: “Headache Care for All: Embracing the Challenge,” reflects the organization’s commitment to improving the lives of all who live with headache from the most fortunate to the most underserved communities, by expanding their access to trained healthcare professionals.

Similarly, Dr. Cohen has also recently expanded his medical reach in helping headache and migraine patients by opening three independent offices in Queens, New York, Brooklyn, New York and Jacksonville, Florida under the newly created private practice Headache Intervention, PLLC. The practice offers personalized care, same day, evening, weekend and telemedicine appointments for the treatment of all types of headaches and facial pain, including migraine, chronic migraine, tension headaches, TMJ disorders, cluster headaches, trigeminal neuralgia and many others.

“At Headache Intervention, I can provide care without the constraints imposed by insurance companies and large hospital systems,” said Dr. Cohen. “This independence allows me to offer treatments round the clock and to manage the prior authorizations and peer-to-peer evaluations myself, streamlining a process that in larger institutions is often delayed by multiple departments. As a result, I feel more confident, effective, and fulfilled in providing the focused, timely, and compassionate headache care that my patients deserve.”

For more information about Dr. Fred Cohen and Headache Intervention, please visit: www.headache123.com.

About Dr. Fred Cohen

Fred Cohen, MD, is one of the few headache specialists in the U.S. trained in both Internal Medicine and Headache Medicine. Based in New York, New York and Jacksonville, Florida, the world-renowned Headache Specialist is Assistant Professor of Medicine and Neurology at the Icahn School of Medicine at Mount Sinai. Dr. Cohen is Assistant Editor of Headache: The Journal of Head and Face Pain and Current Pain and Headache Reports. His research and expertise have made him a highly sought after presenter at headache conferences around the world. For more information, visit: www.headache123.com.